The David H. Koch Institute for Integrative Cancer Research and the BioMicro Center at the Massachusetts Institute of Technology are collaborating with Diagenode to automate assays for ChIP-seq and methyl-seq experiments.

The MIT researchers conducted "extensive tests" of Diagenode's SX-8G IP-Star system to validate its use in automating the design of epigenetic assays and next-gen sequencing library preparation. They are also using the system as a quality control for screening antibodies for ChIP-seq experiments.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.